KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Change in Acquisitions & Divestments: 2018-2025

Historic Change in Acquisitions & Divestments for Adaptive Biotechnologies (ADPT) over the last 7 years, with Sep 2025 value amounting to $50.9 million.

  • Adaptive Biotechnologies' Change in Acquisitions & Divestments fell 26.14% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $250.5 million, marking a year-over-year decrease of 34.97%. This contributed to the annual value of $325.7 million for FY2024, which is 42.85% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Change in Acquisitions & Divestments stood at $50.9 million, which was down 7.72% from $55.1 million recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Change in Acquisitions & Divestments peaked at $155.0 million during Q4 2021, and registered a low of $35.0 million during Q2 2022.
  • Over the past 3 years, Adaptive Biotechnologies' median Change in Acquisitions & Divestments value was $90.3 million (recorded in 2024), while the average stood at $98.1 million.
  • As far as peak fluctuations go, Adaptive Biotechnologies' Change in Acquisitions & Divestments tumbled by 75.78% in 2022, and later soared by 301.15% in 2023.
  • Quarterly analysis of 5 years shows Adaptive Biotechnologies' Change in Acquisitions & Divestments stood at $155.0 million in 2021, then slumped by 54.82% to $70.0 million in 2022, then skyrocketed by 80.63% to $126.5 million in 2023, then crashed by 47.04% to $67.0 million in 2024, then dropped by 26.14% to $50.9 million in 2025.
  • Its last three reported values are $50.9 million in Q3 2025, $55.1 million for Q2 2025, and $77.5 million during Q1 2025.